SCHEMBL125301

SCHEMBL125301

[NH]C(=O)OC(Cl)(Cl)CCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL583307 0.78
SCHEMBL9230924 0.78
SCHEMBL969229 0.76
SCHEMBL3022 0.76
SCHEMBL11203180 0.76
SCHEMBL7439608 0.74 TSHR (0.33)
SCHEMBL573452 0.74
SCHEMBL2171693 0.74 TSHR (0.32)
SCHEMBL1865094 0.74
SCHEMBL9481405 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 509 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115650827-B Preparation method, intermediate compound and synthesis method for anthracycline derivatives 戊言医药科技(上海)有限公司 2024-03-15 CN claimed
CN-115650827-A Preparation method, intermediate compound and synthesis method for anthracycline derivatives 戊言医药科技(上海)有限公司 2023-01-31 CN claimed
EP-2283063-A1 SYNTHESIS OF HYBRID BLOCK COPOLYMERS FROM DIFLUOROACETATE AMMONIUM SALTS Intezyne Technologies Inc. (US) 2011-02-16 EP claimed
US-20090286938-A1 SYNTHESIS OF HYBRID BLOCK COPOLYMERS FROM DIFLUOROACETATE AMMONIUM SALTS INTEZYNE TECHNOLOGIES, INC. (US) 2009-11-19 US claimed
WO-2009134984-A1 SYNTHESIS OF HYBRID BLOCK COPOLYMERS FROM DIFLUOROACETATE AMMONIUM SALTS INTEZYNE TECHNOLGIES INC. (US) 2009-11-05 WO claimed
US-7612153-B2 conjugate polymer drugs; endcapped polyethers; nontoxic, biocompatible, non-immunogenic, soluble in water and other solvents INTEZYNE TECHNOLOGIES, INC. (US) 2009-11-03 US claimed
EP-0313960-B1 STEROIDS SUBSTITUTED IN POSITION 10 BY A RADICAL CONTAINING A DOUBLE OR TRIPLE BOND, AND PROCESS FOR THEIR PREPARATION ROUSSEL-UCLAF (FR) 1992-07-29 EP claimed
US-4987128-A ANTIALDOSTERONES, NATRIURETICS ROUSSEL UCLAF (FR) 1991-01-22 US claimed
EP-0237397-B1 STEROIDS SATURATED IN 9(11) AND SUBSTITUTED IN POSITION 10 BY A RADICAL CONTAINING A TRIPLE BOND, PROCESS FOR THEIR PREPARATION, THEIR USE AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ROUSSEL-UCLAF (FR) 1990-02-07 EP claimed
EP-0313960-A1 Steroids substituted in position 10 by a radical containing a double or triple bond, and process for their preparation ROUSSEL-UCLAF (FR) 1989-05-03 EP claimed
EP-0176399-B1 STEROIDS SUBSTITUTED IN POSITION 10 BY A RADICAL CONTAINING A DOUBLE OR TRIPLE BOND, PROCESS FOR THEIR PREPARATION, THEIR USE AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ROUSSEL-UCLAF (FR) 1989-04-26 EP claimed
US-4474968-A Cyclopentene derivatives THE UPJOHN COMPANY (US) 1984-10-02 US claimed
US-4458089-A ANTITUMOR AGENTS, MICROBIOCIDES THE UPJOHN COMPANY (US) 1984-07-03 US claimed
US-4144333-A Monocyclic beta-lactams with antibacterial activity SMITHKLINE CORPORATION (US) 1979-03-13 US claimed
US-3951955-A ANTIMICROBIAL SUMITOMO CHEMICAL COMPANY, LIMITED (JA) 1976-04-20 US claimed
US-20240212788-A1 HUMAN THERAPEUTIC TARGETS AND MODULATORS THEREOF LIFEMINE THERAPEUTICS, INC. 2024-06-27 US disclosed
WO-2024130217-A1 STAPLED PEPTIDES AND METHODS THEREOF FOG PHARMACEUTICALS, INC. (US) 2024-06-20 WO disclosed
US-3985764-A REACTING CHLORINATED ESTERS OF ANHYDROBENZYLPENICILLIN WITH ALUMINA OR SILICA GEL QUEEN'S UNIVERSITY (CA) 1976-10-12 US disclosed
US-3950352-A ANTIBIOTICS, OXAPENICILLINS QUEEN'S UNIVERSITY (CA) 1976-04-13 US disclosed
US-3948927-A ANTIBIOTIC INTERMEDIATE QUEEN'S UNIVERSITY (CA) 1976-04-06 US disclosed